Rony Avritscher, M.D., F.S.I.R.
Department of Interventional Radiology, Division of Diagnostic Imaging
About Dr. Avritscher
Dr. Rony Avritscher is a Professor and co-chair of the pre-clinical research program in the Department of Interventional Radiology. Dr. Avritscher earned his medical degree from the University of Sao Paulo, in Sao Paulo, Brazil. He completed his radiology residency at the University of Texas Medical School at Houston and Interventional Radiology Fellowship at MD Anderson Cancer Center and subsequently joined the faculty in 2006. He is certified by the American Board of Radiology and holds a Certificate of Added Qualification in Interventional Radiology.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Diagnostic and Interventional Imaging, Division of Diagnostic Imaging, The University of Texas Medical School at Houston, Houston, Texas
Research Interests
Dr. Avritscher’s main research focus is image-guided interventions for hepatocellular carcinoma and other liver cancers, including translational research in animal models of liver disease and catheter-based therapies. He is interested in innovative ways to enhance the efficacy of our minimally-invasive approaches. Recent insights into liver cancer signaling pathways pose a unique opportunity to develop targeted therapies that can be combined with our techniques, thus improving treatment efficacy and potentially increasing patient survival. He is the recipient of several grants to investigate image-guided minimally-invasive therapies in liver cancer
Education & Training
Degree-Granting Education
| 1995 | University of Sao Paulo Medical School, Sao Paulo, BR, MD |
Postgraduate Training
| 2011-2012 | Heart of Leadership Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2003-2004 | Clinical Fellowship, Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1999-2003 | Clinical Residency, Diagnostic Radiology, The University of Texas Health Science Center, Houston, Texas |
| 1998-1999 | Clinical Internship, General Surgery, The University of Texas Health Science Center, Houston, Texas |
| 1996-1998 | Clinical Residency, Diagnostic Radiology, University of Sao Paulo Medical School, Sao Paulo |
Board Certifications
| 2024 | Advanced Cardiovascular Life Support |
| 2007 | Certificate of Added Qualification in Vascular and Interventional Radiology, American Board of Radiology |
| 2003 | American Board of Radiology, Interventional Radiology/Diagnostic Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Administrative Appointments/Responsibilities
Director of Preclinical Research, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2020
Other Appointments/Responsibilities
Chair, Interventional Radiology Research Seminar Series, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present
Institutional Committee Activities
Member, Promotion & Tenure Committee-Clinical, 2024 - 2027
Member, Mentorship Committee for Dr. Simone Anfossi, 2024 - Present
Chair, RSNA IR Annual Meeting Planning Committee, 2024 - 2026
Chair, Research Steering Committee, 2024 - Present
Member, Hospital Medicine Department Chair Search Committee, 2022 - 2024
Member, Diagnostic Imaging Clinical Research Prioritization Committee, 2021 - Present
Vice Chair, Research Steering Committee, 2021 - 2024
Member, Ultrasound Advisory Subcommittee, 2020 - Present
Member, Credentials Committee of the Medical Staff, 2020 - 2023
Member, Institutional Review Board (IRB), 2019 - 2023
Member, Academic Review Committee, 2019 - 2023
Member, Poster Day Review Committee, 2019 - 2019
Member, DI-Research Functional Committee Industry Strategic Partnership (ISC) sub-committee, 2019 - 2020
Member, Credentials Committee of the Medical Staff, 2015 - 2017
Member, Professional Education Committee, 2011 - 2019
Member, Grant Review Sub-Committee, 2011 - 2024
Member, Communications Committee, 2011 - 2019
Member, Research Policy Committee, 2011 - 2019
Member, Clinical Research Committee, 2010 - 2012
Member, Medical Record Committee, 2009 - 2011
Honors & Awards
| 2024 | Fellowship Status, Society of Interventional Radiology |
| 2023 | Certificate of Merit Award - Education Exhibit, Radiological Society of North America |
| 2023 | Keynote Lecture, China Conference on Interventional Oncology |
| 2023 | Fellowship Status, Society of Interventional Radiology |
| 2022 | Fellowship Status, Society of Interventional Radiology |
| 2021 | FY21 DI Outstanding Research Award, Basic and/or Translational Research, The University of Texas MD Anderson Cancer Center |
| 2021 | Fellowship Status, Society of Interventional Radiology |
| 2020 | Fellowship Status, Society of Interventional Radiology |
| 2019 | Fellowship Status, Society of Interventional Radiology |
| 2019 | Distinguished Laboratory Investigation at 2019 Society of Interventional Oncology Conference, Society of Interventional Oncology |
| 2018 | Fellowship Status, Society of Interventional Radiology |
| 2014 | Editor’s Award for Outstanding Laboratory Investigation 2014, Journal of Vascular and Interventional Radiology |
| 2013 | Distinguished Abstract, Society of Interventional Radiology |
| 2012 | 1st Place for Scientific Exhibit, Global Embolization Symposium and Technologies (G.E.S.T.) |
| 2011 | Advanced Course in Grant Writing Award, Radiological Society of North America |
| 2008 | Distinguished Reviewer Award, Journal of Vascular Interventional Radiology |
| 2003 | Cum Laude Award for Scientific Presentation, Radiological Society of North America |
| 2002 | Roentgen Resident Research Award |
| 2001 | Introduction to Research Training Program, Radiological Society of North America |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Lee S, Ko MJ, Avritscher R, Lewandowski RJ, Kim DH. Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors. ACS Nano 18(35):24269-24282, 2024. PMID: 39175187.
- Jonasch D, Habibollahi P, Kyle Jones A, Avritscher R, Habra MA, Perrier ND, Graham PH, Huang SY. Pre-procedural and intra-procedural computerized tomography: providing a roadmap for successful adrenal venous sampling procedures. Abdom Radiol (NY) 49(7):2401-2407, 2024. e-Pub 2024. PMID: 38740580.
- Taiji R, Cortes AC, Zaske AM, Williams M, Dupuis C, Tanaka T, Nishiofuku H, Chintalapani G, Peterson CB, Avritscher R. Liver Cancer Vascularity Driven by Extracellular Matrix Stiffness: Implications for Imaging Research. Invest Radiol 58(12):894-902, 2023. e-Pub 2023. PMID: 37403975.
- Barcena AJR, Perez JVD, Bernardino MR, Damasco JA, Cortes A, Del Mundo HC, San Valentin EMD, Klusman C, Canlas GM, Heralde FM, Avritscher R, Fowlkes N, Bouchard RR, Cheng J, Huang SY, Melancon MP. Bioresorbable Mesenchymal Stem Cell-Loaded Electrospun Polymeric Scaffold Inhibits Neointimal Hyperplasia Following Arteriovenous Fistula Formation in a Rat Model of Chronic Kidney Disease. Adv Healthc Mater 12(26):e2300960, 2023. e-Pub 2023. PMID: 37395729.
- Lin YM, Fellman BM, Taiji R, Paolucci I, Silva JAM, Koay EJ, Avritscher R, Mahvash A, Holliday EB, Lee SS, Kaseb AO, Das P, Vauthey JN, Odisio BC. Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes. J Gastrointest Surg 27(9):1867-1875, 2023. e-Pub 2023. PMID: 37268830.
- Barcena AJR, Perez JVD, Damasco JA, Bernardino MR, San Valentin EMD, Klusman C, Martin B, Cortes A, Canlas GM, Del Mundo HC, Heralde FM, Avritscher R, Fowlkes N, Bouchard RR, Cheng J, Huang SY, Melancon MP. Gold Nanoparticles for Monitoring of Mesenchymal Stem-Cell-Loaded Bioresorbable Polymeric Wraps for Arteriovenous Fistula Maturation. Int J Mol Sci 24(14), 2023. e-Pub 2023. PMID: 37511512.
- Taiji R, Lin YM, Chintalapani G, Lin EY, Huang SY, Mahvash A, Avritscher R, Liu CA, Lee RC, Resende V, Nishiofuku H, Tanaka T, Kichikawa K, Klotz E, Gupta S, Odisio BC. A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis. Eur Radiol Exp 7(1):4, 2023. e-Pub 2023. PMID: 36717474.
- Habibollahi P, Odisio BC, Gurusamy V, Kuban JD, Avritscher R, Abdelsalam ME, Chasen BA, Murthy R, Mahvash A. Temporary reversal of hepatoenteric collaterals during 90Y radioembolization planning and administration. Curr Oncol 29(12):9582-9592, 2022. e-Pub 2022. PMID: 36547167.
- Barekatain Y, Khadka S, Harris K, Delacerda J, Yan VC, Chen KC, Pham CD, Uddin MN, Avritscher R, Eisenberg EJ, Kalluri R, Millward SW, Muller FL. Quantification of Phosphonate Drugs by 1H-31P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice. Anal Chem 94(28):10045-10053, 2022. e-Pub 2022. PMID: 35792073.
- Westerman ME, Yevich SM, Dori Y, Ward JF, Pisters LL, Karam JA, Wood CG, Avritscher R, Matin SF. Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urologic surgery. BJU Int 129(5):585-587, 2022. e-Pub 2022. PMID: 34962705.
- Cortes AC, Nishiofuku H, Polak U, Minhaj AA, Lopez MS, Kichikawa K, Qayyum A, Whitley EM, Avritscher R. Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma. Nanomedicine 39:102465, 2022. e-Pub 2021. PMID: 34571240.
- Kaseb AO, Haque A, Vishwamitra D, Hassan MM, Xiao L, George B, Sahu V, Mohamed YI, Carmagnani Pestana R, Lombardo JL, Avritscher R, Yao JC, Wolff RA, Rashid A, Morris JS, Amin HM. Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma. Front Oncol 12:986305, 2022. e-Pub 2022. PMID: 36276070.
- Abdelsalam ME, Figueira TMA, Ensor J, Tam AL, Avritscher R, Kaseb A, Gupta S. The Impact of the use of C-Arm Cone-Beam CT during Chemoembolization for Hepatocellular Carcinoma. Curr Med Imaging 18(4):372-380, 2022. e-Pub 2021. PMID: 34420509.
- Teyateeti A, Mahvash A, Long J, Abdelsalam M, Avritscher R, Kaseb A, Odisio B, Ravizzini G, Surasi D, Teyateeti A, Macapinlac H, Kappadath SC. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World J Gastroenterol 27(47):8166-8181, 2021. PMID: 35068861.
- Melancon MP, Yevich S, Avritscher R, Swigost A, Lu L, Tian L, Damasco JA, Dixon K, Cortes AC, Munoz NM, Liang D, Liu D, Tam AL. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. Drug Deliv 28(1):240-251, 2021. e-Pub 2021. PMID: 33501859.
- Taiji R, Lin EY, Lin YM, Yevich S, Avritscher R, Sheth RA, Ruiz JR, Jones AK, Chintalapani G, Nishiofuku H, Tanaka T, Kichikawa K, Gupta S, Odisio BC. Combined angio-CT systems: a roadmap tool for precision therapy in interventional oncology. Radiol Imaging Cancer 3(5):e210039, 2021. PMID: 34559007.
- Abdelsalam M, Figueira TM, Ensor J, Tam A, Avritscher R, Kaseb A, Gupta S. Survival impact of C-Arm Cone-Beam computed tomography on hepatocellular carcinoma patients undergoing chemoembolization. AJIR 5(9):None, 2021. PMID: None.
- Qayyum A, Bhosale P, Aslam R, Avritscher R, Ma J, Pagel MD, Sun J, Mohamed Y, Rashid A, Beretta L, Kaseb AO. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. Abdom Radiol (NY) 46(3):1008-1015, 2021. e-Pub 2020. PMID: 32974761.
- Muñoz NM, Williams M, Dixon K, Dupuis C, McWatters A, Avritscher R, Manrique SZ, McHugh K, Murthy R, Tam A, Naing A, Patel SP, Leach D, Hartgerink JD, Young S, Prakash P, Hwu P, Sheth RA. Influence of injection technique, drug formulation, and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. J Immunother Cancer 9(2), 2021. PMID: 33589526.
- Kaseb AO, Kappadath SC, Lee SS, Raghav KP, Mohamed YI, Xiao L, Morris JS, Ohaji C, Avritscher R, Odisio BC, Kuban J, Abdelsalam ME, Chasen B, Elsayes KM, Elbanan M, Wolff RA, Yao JC, Mahvash A. A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. J Hepatocell Carcinoma 35(15 suppl):1129-1145, 2021. e-Pub 2021. PMID: 34527608.
- Muñoz NM, Dupuis C, Williams M, Dixon K, McWatters A, Avritscher R, Bouchard R, Kaseb A, Schachtschneider KM, Rao A, Sheth RA. Molecularly targeted photothermal ablation improves tumor specificity and immune modulation in a rat model of hepatocellular carcinoma. Commun Biol 3(1):783, 2020. e-Pub 2020. PMID: 33335270.
- Avritscher R, Jo N, Polak U, Cortes AC, Nishiofuku H, Odisio BC, Takaki H, Tam AL, Melancon MP, Yevich S, Qayyum A, Kaseb A, Kichikawa K, Gupta S, Goldberg SN, Chang SH. Hepatic arterial bland embolization increases Th17 cell infiltration in a syngeneic rat model of hepatocellular carcinoma. Cardiovasc Intervent Radiol 43(2):311-321, 2020. e-Pub 2019. PMID: 31591689.
- Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients. J Hepatocell Carcinoma 7(None):117-131, 2020. e-Pub 2020. PMID: 32984089.
- Shi D, Kiefer RM, Nishiofuku H, Cortes A, Nadolski GJ, Hunt SJ, Avritscher R, Gade TPF. Angiographic atlas of the visceral vascular anatomy in translational rat models. J Vasc Interv Radiol 30(12):2009-2015.e1, 2019. e-Pub 2019. PMID: 31202678.
- Qayyum A, Hwang KP, Stafford J, Verma A, Maru DM, Sandesh S, Sun J, Pestana RC, Avritscher R, Hassan MM, Amin H, Rashid A, Wistuba II, Ehman RL, Ma J, Kaseb AO. Immunotherapy Response Evaluation with Magnetic Resonance Elastography (MRE) in Advanced HCC. J Immunother Cancer 7(1):329, 2019. e-Pub 2019. PMID: 31779702.
- Muñoz NM, Minhaj AA, Maldonado KL, Kingsley CV, Cortes AC, Taghavi H, Polak U, Mitchell JM, Ensor JE, Bankson JA, Rashid A, Avritscher R. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma. Magn Reson Imaging 57(None):156-164, 2019. e-Pub 2018. PMID: 30465870.
- Naser MA, Sampaio DRT, Munoz NM, Wood CA, Mitcham TM, Stefan W, Sokolov KV, Pavan TZ, Avritscher R, Bouchard RR. Improved photoacoustic-based oxygen saturation estimation with SNR-regularized local fluence correction. IEEE Trans Med Imaging 38(2):561-571, 2019. e-Pub 2018. PMID: 30207951.
- Nishiofuku H, Cortes AC, Ensor JE, Minhaj AA, Polak U, Lopez MS, Kiefer R, Hunt SJ, Kichikawa K, Hicks ME, Gade TP, Avritscher R. Factors impacting technical success rate of image-guided intra-arterial therapy in rat orthotopic liver tumor model. Am J Transl Res 11(6):3761-3770, 2019. e-Pub 2019. PMID: 31312386.
- Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple renal artery pseudoaneurysms in patients undergoing renal artery embolization following partial nephrectomy: correlation with RENAL nephrometry scores. Cardiovasc Intervent Radiol 40(2):202-209, 2017. e-Pub 2016. PMID: 27681271.
- Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL. Efficacy of a self-expanding tract sealant device in the reduction of pneumothorax and chest tube placement rates after percutaneous lung biopsy: A matched controlled study using propensity score analysis. Cardiovasc Intervent Radiol 40(2):270-276, 2017. e-Pub 2016. PMID: 27826786.
- Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural history of T1N0M0 hepatocellular carcinoma: large-scale study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
- Abdelsalam ME, Mahvash A, Avritscher R, McRae SE, Odisio BC. Balloon-assisted flow diversion and selective catheterization of target vessels for hepatic transarterial embolization. J Vasc Interv Radiol 27(2):283-5, 2016. PMID: 26830942.
- Mitchell J, Tinkey PT, Avritscher R, Van Pelt C, Eskandari G, Konnath George S, Xiao L, Cressman E, Morris JS, Rashid A, Kaseb AO, Amin HM, Uthamanthil R. Validation of a preclinical Model of Diethylnitrosamine-induced hepatic neoplasia in Yucatan miniature pigs. Oncology 91(2):90-100, 2016. e-Pub 2016. PMID: 27305144.
- Kuban JD, Tam AL, Huang SY, Ensor JE, Philip AS, Chen GJ, Ahrar J, Murthy R, Avritscher R, Madoff DC, Mahvash A, Ahrar K, Wallace MJ, Nachiappan AC, Gupta S. The effect of needle gauge on the risk of pneumothorax and chest tube placement after percutaneous computed tomographic (CT)-guided lung biopsy. Cardiovasc Intervent Radiol 38(6):1595-1602, 2015. e-Pub 2015. PMID: 25920917.
- Steele JR, Jones AK, Ninan EP, Clarke RK, Odisio BC, Avritscher R, Murthy R, Mahvash A. Why bundled payments could drive innovation: an example from interventional oncology. J Oncol Pract 11(2):e199-205, 2015. e-Pub 2015. PMID: 25604596.
- Pusztai L, Moulder S, Altan M, Kwiatkowski D, Valero V, Ueno NT, Esteva FJ, Avritscher R, Qi Y, Strauss L, Hortobagyi GN, Hatzis C, Symmans WF. Gene signature-guided Dasatinib therapy in metastatic breast cancer. Clin Cancer Res 20(20):5265-71, 2014. e-Pub 2014. PMID: 25172932.
- Zhao J, Vykoukal J, Abdelsalam M, Recio-Boiles A, Huang Q, Qiao Y, Singhana B, Wallace M, Avritscher R, Melancon MP. Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma. Nanotechnology 25(40):405101, 2014. e-Pub 2014. PMID: 25211057.
- Tam AL, Abdelsalam ME, Gagea M, Ensor JE, Moussa M, Ahmed M, Goldberg SN, Dixon K, McWatters A, Miller JJ, Srimathveeravalli G, Solomon SB, Avritscher R, Wallace MJ, Gupta S. Irreversible electroporation of the lumbar vertebrae in a porcine model: is there clinical-pathologic evidence of neural toxicity?. Radiology 272(3):709-19, 2014. e-Pub 2014. PMID: 24766034.
- Odisio BC, Galastri F, Avritscher R, Afonso BB, Segatelli V, Felga GE, Salvalaggio PR, Ensor J, Wallace MJ, Nasser F. Hepatocellular carcinomas within the Milan criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization. Cardiovasc Intervent Radiol 37(4):1018-26, 2014. e-Pub 2013. PMID: 24149832.
- Vasan N, Yelensky R, Wang K, Moulder S, Dzimitrowicz H, Avritscher R, Wang B, Wu Y, Cronin MT, Palmer G, Symmans WF, Miller VA, Stephens P, Pusztai L. A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice. Oncologist 19(5):453-8, 2014. e-Pub 2014. PMID: 24710307.
- Huang SY, Abdelsalam ME, Harmoush S, Ensor JE, Chetta JA, Hwang KP, Stafford RJ, Madoff DC, Avritscher R. Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis. J Magn Reson Imaging 39(3):590-7, 2014. e-Pub 2013. PMID: 24532376.
- Avritscher R, Abdelsalam ME, Javadi S, Ensor J, Wallace MJ, Alt E, Madoff DC, Vykoukal JV. Percutaneous intraportal application of adipose tissue-derived mesenchymal stem cells using a balloon-occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol 24(12):1871-1878, 2013. e-Pub 2013. PMID: 24144538.
- Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam ME, Madoff DC, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. Acta Radiol 54(7):790-794, 2013. e-Pub 2013. PMID: 23535183.
- Tsimberidou AM, Leick MB, Lim J, Fu S, Wheler J, Piha-Paul SA, Hong D, Falchook GS, Naing A, Subbiah IM, Fortier A, Avritscher R, Kurzrock R. Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liver. Cancer Chemother Pharmacol 71(2):389-97, 2013. e-Pub 2012. PMID: 23143207.
- Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Rep Radiol 2013(None):560758, 2013. e-Pub 2013. PMID: 23710405.
- Odisio BC, Tam AL, Avritscher R, Gupta S, Wallace MJ. CT-guided adrenal biopsy: Comparison of ipsilateral decubitus versus prone patient positioning for biopsy approach. Eur Radiol 22(6):1233-1239, 2012. e-Pub 2012. PMID: 22227794.
- Mahvash A, Zaer N, Shaw C, Chasen B, Avritscher R, Murthy R. Temporary balloon occlusion of the common hepatic artery for administration of Yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol 23(2):277-280, 2012. PMID: 22264555.
- Avritscher R, Javadi S. Transcatheter intra-arterial limb infusion for extremity osteosarcoma: technical considerations and outcomes. Tech Vasc Interv Radiol 14(3):124-128, 2011. PMID: 21767779.
- Avritscher R, Wright KC, Javadi S, Uthamanthil R, Gupta S, Gagea M, Bassett RL, Murthy R, Wallace MJ, Madoff DC. Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: a study in swine. J Vasc Interv Radiol 22(9):1329-1334, 2011. e-Pub 2011. PMID: 21802316.
- Kumar K, Avritscher R, Wang Y, Lane N, Madoff DC, Yu TK, Uhr JW, Zhang X. Handheld histology-equivalent sectioning laser-scanning confocal optical microscope for interventional imaging. Biomed Microdevices 12(2):223-233, 2010. PMID: 20012209.
- Avritscher R, Krishnamurthy S, Ensor J, Gupta S, Tam A, Madoff DC, Murthy R, Hicks ME, Wallace MJ. Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer 116(8):1974-1980, 2010. e-Pub 2010. PMID: 20151422.
- Vyas A, Avritscher R, Ensor J, Ross M, Wallace MJ. Isolated limb infusion with cytotoxic agents: a simplified approach for venous access. Cancer 116(2):459-464, 2010. e-Pub 2009. PMID: 19924798.
Invited Articles
- Toskich B, Avritscher R, Garcia-Reyes K, Tabori N. Combination Locoregional and Immunotherapy in Practice. Endovascular Today 23(10):33-37, 2024. PMID: None.
- Buchholz TA, Avritscher R, Yu TK. Identifying the "sentinel lymph nodes" for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy. Breast Cancer Res Treat 116(3):539-541, 2009. e-Pub 2009. PMID: 19184413.
- Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff DC. Percutaneous transhepatic portal vein embolization: rationale, technique and outcomes. Semin Intervent Radiol 25(2):132-145, 2008. PMID: 21326554.
- Avritscher R, Sneider GA. Percutaneous gastrostomy. How I do it. Jornal da sobrice 20(None):7-8, 2008. PMID: None.
Manuals, Teaching Aids, Other Teaching Publications
- Avritscher R, Brown D, Madoff DC. Maintenance of Certification (MOC) Self Assessment Module - Portal Venous Embolization. None, 2006.
Other Articles
- Migut AE, Kaur H, Avritscher R Neuroendocrine tumors: Imaging of treatment and follow-up. Radiol Clin North Am 58(6):1161-1171, 2020. PMID: 33040855.
- Niekamp A, Sheth RA, Kuban J, Avritscher R, Ganguli S Palliative embolization for refractory bleeding. Semin Intervent Radiol 34(4):387-397, 2017. PMID: 29249863.
- Abdelsalam ME, Mahvash A, Madoff DC, Odisio BC, Kuban JD, Avritscher R, Murthy R Radioembolization in colorectal metastases: A Review. Digestive Disease Interventions 1(3):208-217, 2017. PMID: None.
- Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC Minimally invasive image-guided therapies for hepatocellular carcinoma. J Hepatocell Carcinoma 3(None):55-61, 2016. PMID: 27785450.
- Odisio BC, Galastri F, Avritscher R, Afonso BB, Segatelli V, Felga GE, Salvalaggio PR, Ensor J, Wallace MJ, Nasser F Erratum to: Hepatocellular carcinomas within the Milan criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization. Cardiovasc Interv Radiol 37(6):1648, 2014. PMID: None.
- Avritscher R, Duke E, Madoff DC Portal vein embolization: rationale, outcomes, controversies and future directions. Expert Rev Gastroenterol Hepatol 4(4):489-501, 2010. PMID: 20678021.
- Avritscher R, Gupta S Gastrointestinal stromal tumor: role of interventional radiology in diagnosis and treatment. Hematol Oncol Clin North Am 23(1):129-137, 2009. PMID: 19248976.
- Avritscher R, Madoff DC, Ramirez PT, Wallace MJ, Ahrar K, Morello FA, Gupta S, Murthy R, Wright KC, Hicks ME Fistulas of the lower urinary tract: percutaneous approaches for the management of a difficult clinical entity. Radiographics 24(1):S217-S236, 2004. PMID: 15486242.
- Avritscher R, Iyer RB, Ro J, Whitman G Lipoleiomyoma of the uterus. Am J Roentgenol 177(4):856, 2001. PMID: 11566688.
Abstracts
- Avritscher R, Madoff D, Ramirez P, Hicks M. Urinary fistulae: percutaneous approaches in the management of a difficult clinical entity. Radiology 229(None):764, 2003. e-Pub 2003. PMID: None.
- Lin E, Chintalapani G, Brock K, Avritscher R, Odisio B. Intra-arterial CT arteriography for tumor detection and ablation endpoint assessment. CARS. PMID: None.
Book Chapters
- Yedururi S, Salem U, Avritscher R, Loyer E. Imaging Response Evaluation. In: Colorectal Liver Metastisis. None. Springer Cham, 417-439, 2022.
- Avritscher, R. Interventional Imaging in the Oncologic Patient. In: Oncology Imaging: a Multidisciplinary Approach. 2. Elsevier, 670-680, 2022.
- Uemura M, Krishnan S, Kaseb AO, Bhadkamker NA, Javle M, Avritscher R. Hepatocellular Carcinoma. In: The MD Anderson Manual of Medical Oncology. Third. McGraw Hill, 463-478, 2016.
- Shaw C, Odisio BC, Avritscher R, Madoff DC. Nodes and Soft Tissue Masses Involving the Retroperitoneum, Mesentery, Omentum Peritoneal Ligaments. In: Percutaneous Image-Guided Biopsy. None. Springer Science+Business Media, 267 - 279, 2013.
- Avritscher R, Wallace MJ. Principles of embolization. In: Interventional Oncology: A Practical Guide for the Interventional Radiologist. None. Springer Science+Business Media, LLC, 81-86, 2012.
- Wallace MJ, Avritscher R. Principles of Liver Embolization. In: Interventional Oncology: A Practical Guide for the Interventional Radiologist. None. Springer Science+Business Medica, LLC, 95-106, 2012.
- Madoff DC, Avritscher R. Portal Vein Embolization Prior to Resection. In: Hepatocellular Carcinoma. None. None, 153-183, 2011.
- Nishin A, Milind B, Javle M, Avritscher R, Krishnan S, Kaseb AO. Hepatobiliary malignancies. In: The MD Anderson Manual of Medical Oncology. 2nd. The McGraw Hill, Chapter 19, 2011.
- Madoff DC, Avritscher R. Portal vein embolization prior to resection. In: Hepatocellular Carcinoma. None. Springer Science+Business Media, LLC 2010, None, 2010.
- Avritscher R, Wallace M. Interventional radiology for the cancer patient. In: Cancer Medicine. 8th. B.C. Decker, 490-497, 2010.
- Madoff DC, Avritscher R. Portal vein embolization. In: Handbook of Interventional Radiology. 4th. None, 2010.
- Brown D, Waybill P, Avritscher R. Periprocedural management of fluids, electrolytes and acid-base disturbances. In: Patient Care in Vascular and Interventional Radiology. 2nd. Society of Interventional Radiology, None, 2009.
Grant & Contract Support
| Title: | A Ph III, Randomized, Open-Label, Sponsor-Blinded, Multicenter Study of Durvalumab in Combination with Tremelimumab +/- Lenvtanib Given Concurrently with TACE Compared to TACE Alone in Patients with Locoregional HCC (EMERALD-3) |
| Funding Source: | AstraZeneca |
| Role: | PI |
| Title: | Liver tumor immune environment: imaging and modulation after therapy |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| Title: | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| Title: | A randomized embolization trial for NeuroEndocrine tumor metastases to the liver (RETNET): randomized trial to compare hepatic progression-free survival following bland embolization, lipodol chemoembolizatlon, and drug-eluting bead chemoembolizatlon |
| Funding Source: | Guerbet, LLC |
| Role: | Co-PI |
| Title: | MDA Avritscher Preclinical Oncology |
| Funding Source: | Siemens Medical Solutions, Inc |
| Role: | PI |
| Title: | Real-time matrix imaging for monitoring local liver cancer therapy |
| Funding Source: | Adverse Incident Bridge Funding (IRG) |
| Role: | PI |
| Title: | Real-time intraoperative stromal imaging to enhance HCC treatment |
| Funding Source: | Institutional Research Grant (IRG) |
| Role: | PI |
| Title: | Reducing post embolization immunosuppression with lipiodol TACE |
| Funding Source: | Society of Interventional Oncology and Guerbet, LLD |
| Role: | PI |
| Title: | Strategies to modulate liver tumor immune microenvironment after catheter-based drug delivery |
| Funding Source: | Society of Interventional Oncology |
| Role: | PI |
| Title: | Clinical trials of C188-9, an oral inhibitor of signal transducer and activator of transcription (STAT) 3, in patients with hepatocellular carcinoma (HCC) |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| Title: | Imaging-based quantitative analysis of vascular perfusion and tissue oxygenation to improve therapy of hepatocellular carcinoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Intravital imaging of drug-eluting beads in an animal model of hepatocellular carcinoma |
| Funding Source: | Biocompatibles, Inc |
| Role: | PI |
| Title: | Clinical relevance of FGF19-FGFR4 signaling in the resistance to image-guided therapy in hepatocellular carcinoma |
| Funding Source: | MDACC Sister Institution Network Fund |
| Role: | Co-PI |
| Title: | Adjunctive Use of Mesenchymal Stem Cells to Enhance Tumor Destruction After Radiofrequency Ablation for Hepatocellular Carcinoma |
| Funding Source: | Radiological Society of North America (RSNA) |
| Role: | PI |
| Title: | Investigation of correlation between the lymphatic systems of upper extremity and breast using 3D CT in cadaver models |
| Funding Source: | The University of Texas MD Anderson Cancer Center Sister Institution Network Fund (SINF) |
| Role: | Collaborator |
| Title: | Pilot program for early detection of hepatocellular carcinoma (HCC) in underserved communities: development and validation of prognostic markers |
| Funding Source: | The University of Texas MD Anderson Cancer Center Sister Institution Network Fund (SINF) |
| Role: | Co-PI |
| Title: | Performance evaluation of irreversible electroporation for resection of soft tissue |
| Funding Source: | Angiodynamics |
| Role: | Co-I |
| Title: | Clinically relevant large animal model for early and effective translation of preventive, diagnostic and therapeutic strategies in hepatocellular carcinoma |
| Funding Source: | University of Texas MD Anderson Cancer Center G. S. Hogan Gastrointestinal Research Fund |
| Role: | Collaborator |
| Title: | Portal vein application of mesenchymal stem cells in a large animal model of hepatic cirrhosis: analysis of distribution, differentiation, and effect on liver function |
| Funding Source: | SIR Foundation |
| Role: | PI |
Patient Reviews
CV information above last modified November 21, 2024